...
首页> 外文期刊>Genomics >Analysis of relapse-associated alternative mRNA splicing and construction of a prognostic signature predicting relapse in I–III colon cancer
【24h】

Analysis of relapse-associated alternative mRNA splicing and construction of a prognostic signature predicting relapse in I–III colon cancer

机译:复发相关替代MRNA剪接及预测染色中的预后癌症的构建分析

获取原文

摘要

The literature comprehensively analyzed alternative splicing (AS) events in colon cancer is little and corresponding prognostic signature is still a lack. Based on data of TCGA, the relapse-associated ASs were comprehensively analyzed and a signature was further constructed to predict the relapse in I–III colon cancer. In total 1912 ASs of 1384 mRNA were identified as relapse-associated ASs, protein-protein interactions (PPI) and ASs-splicing factors (SF) interactions network were identified. We finally built a robust signature to predict the relapse of I–III colon cancer with a considerable AUC value in both the training group and the test group. The AUC in the entire set at 1, 3 and 5?year was 0.85, 0.83 and 0.836. Our study provided a profile of relapse-associated ASs in I–III colon cancer and built a robust signature to predict the relapse of I–III colon cancer.
机译:文献综合分析了结肠癌的替代剪接(AS)事件几乎没有,相应的预后签名仍然是缺乏。基于TCGA的数据,全面分析复发相关的屁股,进一步构建签名以预测I-III结肠癌的复发。总共1912年的1384个mRNA被鉴定为复发相关的屁股,鉴定了蛋白质 - 蛋白质相互作用(PPI)和浆浆系列(SF)相互作用网络。我们终于建立了一个强大的签名,以预测培训组和测试组中具有相当大的AUC值的I-III结肠癌的复发。整个集合的AUC在1,3和5?年为0.85,0.83和0.836。我们的研究提供了在I-III癌症中复发相关屁股的型材,并建立了一种稳健的签名,以预测I-III癌症的复发。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号